In vitro activity of imipenem-relebactam against KPC-producing Klebsiella pneumoniae resistant to ceftazidime-avibactam and/or meropenem-vaborbactam

被引：16
|
作者：
Lombardo, Donatella [1 ]
Ambretti, Simone [1 ]
Lazzarotto, Tiziana [1 ]
Gaibani, Paolo [1 ]
机构：
[1] IRCCS Azienda Osped Univ Bologna, Operat Unit Clin Microbiol, Bologna, Italy
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2022年 / 28卷 / 05期
关键词：
D O I：
10.1016/j.cmi.2022.01.025
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：749 / 751
页数：3
相关论文
共 50 条
  • [1] Review of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem-Vaborbactam and Imipenem-Relebactam in Carbapenemase Producing Klebsiella pneumoniae Isolates
    Aydemir, Ozlem
    Koroglu, Mehmet
    Sahin, Elif Ozozen
    Vural, Sevinc
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2023, 12
  • [2] Comparative In Vitro Activity of Ceftazidime-Avibactam, Imipenem-Relebactam, and Meropenem-Vaborbactam against Carbapenem-Resistant Clinical Isolates of Klebsiella pneumoniae and Pseudomonas aeruginosa
    Sophonsri, Anthony
    Kalu, Michelle
    Wong-Beringer, Annie
    ANTIBIOTICS-BASEL, 2024, 13 (05):
  • [3] Klebsiella pneumoniae Mutants Resistant to Ceftazidime-Avibactam Plus Aztreonam, Imipenem-Relebactam, Meropenem-Vaborbactam, and Cefepime-Taniborbactam
    Satapoomin, Naphat
    Dulyayangkul, Punyawee
    Avison, Matthew B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (04)
  • [4] Epidemiology and in vitro activity of ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, eravacycline, plazomicin, and comparators against Greek carbapenemase-producing Klebsiella pneumoniae isolates
    Maraki, Sofia
    Mavromanolaki, Viktoria Eirini
    Magkafouraki, Eleni
    Moraitis, Panagiotis
    Stafylaki, Dimitra
    Kasimati, Anna
    Scoulica, Effie
    INFECTION, 2022, 50 (02) : 467 - 474
  • [5] Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland
    Patrice Nordmann
    Maxime Bouvier
    Laurent Poirel
    European Journal of Clinical Microbiology & Infectious Diseases, 2023, 42 : 1145 - 1152
  • [6] In Vitro Activity of Imipenem-Relebactam, Meropenem-Vaborbactam, Ceftazidime-Avibactam and Comparators on Carbapenem-Resistant Non-Carbapenemase-Producing Enterobacterales
    Bonnin, Remy A.
    Bernabeu, Sandrine
    Emeraud, Cecile
    Naas, Thierry
    Girlich, Delphine
    Jousset, Agnes B.
    Dortet, Laurent
    ANTIBIOTICS-BASEL, 2023, 12 (01):
  • [7] In vitro synergistic activity of meropenem/vaborbactam in combination with ceftazidime/avibactam against KPC-producing Klebsiella pneumoniae
    Gaibani, Paolo
    Ambretti, Simone
    Viale, PierLuigi
    Re, Maria Carla
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (05) : 1457 - 1459
  • [8] Efficacy of ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam combinations against carbapenemase-producing Enterobacterales in Switzerland
    Nordmann, Patrice
    Bouvier, Maxime
    Poirel, Laurent
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023, 42 (09) : 1145 - 1152
  • [9] Comparison of the in vitro activities and resistance mechanisms against imipenem-relebactam and ceftazidime-avibactam in clinical KPC-producing Klebsiella pneumoniae isolated in China
    Guo, Yingyi
    Yao, Likang
    Wang, Jiong
    Zhang, Yan
    Zhuo, Chuyue
    Wang, Yijing
    Yang, Xu
    Li, Jiahui
    He, Nanhao
    Chen, Jiakang
    Lin, Yexin
    Xiao, Shunian
    Lin, Zhiwei
    Zhuo, Chao
    INFECTION, 2025,
  • [10] Looking beyond ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae: in vitro activity of the novel meropenem-vaborbactam in combination with the old fosfomycin
    Matteo, Boattini
    Gabriele, Bianco
    Iannaccone, Marco
    Bondi, Alessandro
    Cavallo, Rossana
    Cristina, Costa
    JOURNAL OF CHEMOTHERAPY, 2021, 33 (08) : 598 - 600
12345